List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 311 studies with search of: Aldesleukin OR Proleukin [TREATMENT] AND HIV [CONDITION]
Hide studies that are not seeking new volunteers.
Hide studies with unknown recruitment status.
  Display Options
Rank Status Study
1 Completed Effect of Intermittent Aldesleukin Treatment With or Without Anti-HIV Drugs in HIV Infected People
Condition: HIV Infections
Intervention: Drug: Aldesleukin
2 Completed A Phase I Study of the Safety of Proleukin (Aldesleukin) in Combination With Ganciclovir and Antiretroviral Therapy in HIV Seropositive Patients With Cytomegalovirus (CMV) Retinitis
Conditions: Cytomegalovirus Retinitis;   HIV Infections
Intervention: Drug: Aldesleukin
3 Completed A Phase I Study of Subcutaneously Administered Proleukin (Aldesleukin) in HIV-Infected Patients
Condition: HIV Infections
Intervention: Drug: Aldesleukin
4 Unknown † Subcutaneously Administered Aldesleukin ( Interleukin-2; IL-2 ) Therapy in HIV-Infected Patients
Condition: HIV Infections
Intervention: Drug: Aldesleukin
5 Completed A Study to Evaluate the Effects of Giving Proleukin (rIL-2) to HIV-Positive Patients With CD4 Counts Greater Than 300 Cells/mm3
Condition: HIV Infections
Intervention: Drug: Aldesleukin
6 Completed
Has Results 		An International Study to Evaluate Recombinant Interleukin-2 (rIL-2) in HIV Positive Patients Taking Anti-retroviral Therapy
Condition: HIV Infections
Intervention: Drug: Recombinant interleukin-2 (rIL-2)
7 Completed A Phase II Study of Intermittent Recombinant Human Interleukin-2 (rhIL-2) by Intravenous or Subcutaneous Administration in Subjects With HIV Infection on Highly Active Antiretroviral Therapy (HAART) Compared to HAART Alone
Condition: HIV Infections
Interventions: Drug: Indinavir sulfate;   Drug: Lamivudine;   Drug: Stavudine;   Drug: Zidovudine;   Drug: Didanosine;   Drug: Aldesleukin
8 Completed Effects of Giving Interleukin-2 (IL-2) Plus Anti-HIV Therapy to HIV-Positive Patients With CD4 Cell Counts of at Least 350 Cells/mm3
Condition: HIV Infections
Interventions: Drug: Aldesleukin;   Drug: ART
9 Completed
Has Results 		Interleukin-2 Plus Antiretroviral Therapy for HIV-Infected Patients With Low CD4+ Counts (SILCAAT Study)
Condition: HIV Infection
Intervention: Drug: Proleukin
10 Completed Aldesleukin in Patients With Metastatic Renal Cell Carcinoma and Metastatic Melanoma
Conditions: Metastatic Renal Cell Carcinoma;   Metastatic Melanoma
Intervention: Drug: Aldesleukin
11 Recruiting Prospective Randomized Comparative Study of Cell Transfer Therapy Using CD8+-Enriched Short-Term Cultured Anti-Tumor Autologous Lymphocytes Following a Non-Myeloablative Lymphocyte Depleting Chemotherapy Regimen Compared to High-Dose Aldesleukin in M...
Conditions: Skin Cancer;   Melanoma;   Metastatic Melanoma
Interventions: Biological: Aldesleukin;   Biological: CD8 enriched Young TIL
12 Recruiting Interleukin 2, Aldesleukin and Entinostat for Kidney Cancer
Condition: Renal Cell Carcinoma
Intervention: Drug: Aldesleukin
13 Unknown † A Study to Evaluate the Use of a Protease Inhibitor and of Interleukin-2 (IL-2) in the Treatment of Early HIV Infection
Condition: HIV Infections
Interventions: Drug: Indinavir sulfate;   Drug: Ritonavir;   Drug: Abacavir sulfate;   Drug: Efavirenz;   Drug: Stavudine;   Drug: Didanosine;   Drug: Aldesleukin
14 Active, not recruiting Busulfan and Etoposide Followed by Peripheral Blood Stem Cell Transplant and Low-Dose Aldesleukin in Treating Patients With Acute Myeloid Leukemia
Conditions: Adult Acute Myeloid Leukemia in Remission;   Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities;   Adult Acute Myeloid Leukemia With Del(5q);   Adult Acute Myeloid Leukemia With t(15;17)(q22;q12);   Adult Acute Myeloid Leukemia With t(16;16)(p13;q22);   Childhood Acute Myeloid Leukemia in Remission;   Recurrent Adult Acute Myeloid Leukemia;   Recurrent Childhood Acute Myeloid Leukemia
Interventions: Drug: busulfan;   Drug: etoposide;   Biological: aldesleukin;   Procedure: peripheral blood stem cell transplantation
15 Completed Interleukin-2 With and Without Antiretroviral Therapy to Treat HIV-1 Infection
Conditions: HIV Infections;   HIV
Intervention: Drug: Interleukin-2, Proleukin
16 Active, not recruiting Aldesleukin With or Without Vaccine Therapy in Treating Patients With Stage IV Melanoma
Condition: Stage IV Melanoma
Interventions: Biological: aldesleukin;   Biological: allogeneic large multivalent immunogen vaccine
17 Recruiting Adjuvant, Combined Interleukin 2 (Proleukin) and DTIC (Dacarbazine) in High-risk Melanoma Patients
Condition: Metastatic Melanoma
Intervention: Drug: Proleukin and Dacarbazine
18 Completed Safety and Efficacy of BAY 50-4798 in Patients With HIV Infection
Condition: HIV Infections
Interventions: Drug: Interleukin-2 SA;   Drug: HAART
19 Completed Phase II Study of Aldesleukin (IL-2) Following the Administration of Zanolimumab (Anti-CD4mAb) in Metastatic Melanoma and Metastatic Renal Cancer
Conditions: Metastatic Melanoma;   Metastatic Renal Cancer
Interventions: Drug: Zanolimumab;   Drug: Aldesleukin
20 Active, not recruiting Therapeutic Autologous Lymphocytes, Cyclophosphamide, and Aldesleukin in Treating Patients With Stage IV Melanoma
Conditions: Recurrent Melanoma;   Stage IV Melanoma
Interventions: Drug: cyclophosphamide;   Biological: therapeutic autologous lymphocytes;   Biological: aldesleukin;   Other: immunohistochemistry staining method;   Procedure: biopsy;   Other: laboratory biomarker analysis;   Other: immunologic technique;   Genetic: polymerase chain reaction

Previous Page Studies Shown (1-20) Next Page (21-40)
† Indicates status has not been verified in more than two years
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services